Head-to-head · Cost-Efficiency Index
Novi vs Tell Her Doc
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Novi
Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site.
Visit NoviTell Her Doc
Cost-first shoppers who want women seeking a well-documented, LegitScript-verified provider -- but get the real recurring price before trusting the $269 headline.
Visit Tell Her DocThe verdict
Novi and Tell Her Doc tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Novi (ranked #105, a hair above #108) — Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site. But Tell Her Doc is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Novi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Novi | Tell Her Doc |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $99/mo (all doses, promotional rate, compounded) | $269/mo (compounded oral) |
| Tirzepatide / mo | $133/mo (all doses, promotional rate, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,188 | $3,228 |
| Tirzepatide / yr (modeled) | $1,596 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #105 | #108 |
Novi
69/100Where the value is
- Lowest advertised entry price in this entire batch for both drugs ($99 semaglutide / $133 tirzepatide)
- LegitScript certified, independently verifiable via the linked legitscript.com record
- States one flat price per dose with no separate visit fee and free shipping
The tradeoffs
- No published mg dose, supply duration, state-coverage list, named medical director, or named compounding pharmacy anywhere on the site or its help center — the least transparent operational disclosure of any company researched in this batch
- The advertised $99/$133 rate is displayed against a live countdown timer ('price increases in...') next to a claimed $299 original price, a scarcity tactic that makes it unclear whether this is a genuine standing rate or a recurring promotional one
Tell Her Doc
69/100Where the value is
- Four named, NPI-verified physicians -- unusually transparent medical leadership for this category
- Four named compounding pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
- Claims and displays coverage across all 50 states
The tradeoffs
- Headline '$269 / $140 off' price is a prepaid, first-time-customer, oral-semaglutide-only promo -- not a general or recurring rate
- No standalone tirzepatide price disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.